Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
330350.KQ
BUYWITHUS PHARMACEUTICAL Co.,LTD. · Healthcare · South Korea · $73M · Avg Vol: $4M/d
66
StockRankQ
61
V
54
M
40
P/E (TTM)
17.9x
ROE
7.4%
D/E
0.2x
Dividend %
—
COMPANY DESCRIPTION
WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 42.1M | 52.2M | 66.9M | 69.3M | 18.1% |
| EPS | 0.12 | 0.39 | 0.24 | 0.24 | 26.0% |
| Shares | 13.2M | 13.2M | 13.2M | 13.2M | +0.1% |
| Debt | 14.0M | 13.0M | 15.7M | 12.2M | -4.5% |
| Equity | 54.1M | 58.8M | 60.6M | 63.8M | 5.7% |
| Op CF | 3.5M | -0.8M | 6.3M | 4.4M | 8.0% |
| Inv CF | -5.1M | 2.1M | -2.4M | -1.2M | — |
| Fin CF | -1.5M | -1.2M | 1.8M | -3.6M | — |
Loading...
PRICE (1Y)-20.7%
SMA 50SMA 200
Close
$4.23
RSI (14)
50.8
52W High
$7.78
From 52W High
0.5%
SCORE BREAKDOWN
Quality
61
ROIC
5.0%57.1
ROE
7.4%63.8
GP/Assets
50.4%86.9
Op. Margin
0.9%46.3
FCF/Assets
-3.0%40.6
Piotroski
997.8
Int. Cover
7.3x55.9
D/E Ratio
0.21x51.4
Current Ratio
2.00x37.1
Value
54
P/E (TTM)
17.9x63.2
EV/EBITDA
12.4x55.6
P/FCF
—N/A
P/B
0.9x86.2
P/S
0.8x86.5
Div Yield
—N/A
Momentum
40
52W High %
54%34.6
RS 6M
-136%5.7
SMA 50/200
1.03x70.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
141%89.1
FUNDAMENTALS
Market Cap
$73M
P/E (Forward)
—
Gross Margin
63.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 330350.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 330350.KQ | WITHUS PHARMACEUTICAL Co.,LTD.(you) | $73M | 66 | BUY |
| 106190.KQ | High Tech Pharm Co., Ltd. | $100M | 66 | BUY |
| 002620.KS | Jeil Pharma Holdings Inc | $68M | 72 | BUY |
| 131030.KQ | DHP Korea Co., Ltd. | $62M | 72 | BUY |
| 293480.KS | Hana Pharm Co., Ltd. | $103M | 61 | HOLD |
| 054670.KQ | Daehan Nupharm Co.,Ltd. | $51M | 62 | HOLD |
| 072020.KQ | Choong Ang Vaccine Laboratory Co., Ltd. | $57M | 77 | BUY |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $98M | 55 | HOLD |
| 000230.KS | Ildong Holdings Co., Ltd. | $57M | 48 | HOLD |
| 003120.KS | Ilsung Is Co., Ltd. | $91M | 47 | HOLD |
Peer medians: ROE 0.1% · P/E 16.1x · Gross margin 43.8%